| ★ | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | |
| 7 | Is Continuous Ketone Monitoring Future of Diabetes Care? | | 270 | Estados Unidos | 62 |
| 20 | Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 59 |
| 4 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 63 |
| 5 | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 63 |
| 13 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 61 |
| 8 | New AI Model Outperforms Standard Echocardiograms in Heart Disease Detection | | 124 | Estados Unidos | 62 |
| 15 | Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 60 |
| 6 | Survey Shows Peptide Misinformation, Misuse Rising in US | | 108 | Estados Unidos | 62 |
| 16 | Lonvo-z at EAACI: Secondary Data & QoL Findings in HAE | Aleena Banerji, MD | | 91 | Estados Unidos | 60 |
| 12 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 61 |
| 9 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 62 |
| 3 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 64 |
| 2 | Improving Heart Failure Care for All, With Joshua Remick, MD | | 59 | Estados Unidos | 64 |
| 19 | AI-Powered ECG and Echo Could Shrink 2.5-Year Diagnostic Delay in PH | | 31 | Estados Unidos | 59 |
| 18 | Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction | | 29 | Estados Unidos | 60 |
| 11 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 61 |
| 17 | IBS-C Treatment Cycling Linked to Higher Healthcare Utilization | | 23 | Estados Unidos | 60 |
| 10 | Structuring Obesity Trials to Optimize Patient Retention and Data Integrity | | 18 | Estados Unidos | 61 |
| 14 | Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D | | 16 | Estados Unidos | 61 |
| 1 | BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS | | 14 | Estados Unidos | 74 |